Recurrent aciclovir‐resistant herpes simplex in a child with Wiskott–Aldrich syndrome
Recurrent aciclovir‐resistant herpes simplex in a child with Wiskott–Aldrich syndrome
复制标题
Wiskott-Aldrich 综合征儿童复发性阿昔洛韦耐药单纯疱疹
DOI:
10.1046/j.1365-2133.1998.02374.x
复制
发表时间:
1998
影响因子:
10.3
通讯作者:
K. Itoh
中科院分区:
文献类型:
--
作者:
Masayuki Saijo;T. Suzutani;K. Murono;Y. Hirano;K. Itoh
A boy with Wiskott–Aldrich syndrome suffered from thymidine kinase (TK)‐altered and aciclovir‐resistant herpes simplex virus type 1 (HSV‐1) skin infections. He presented with severe herpes simplex around the left eye in March 1993 at the age of 8 years. HSV‐1 strain TAS was isolated and was shown to be susceptible to aciclovir (50% inhibitory concentration (IC50) 0.23 μg/mL). He was treated with intravenous (i.v.) high dose aciclovir, 2 mg/kg per h, which produced an improvement. About 1 year later (May 1994), a severe herpes simplex infection appeared on his face, arm, genitalia, back and foot. Treatment with i.v. aciclovir, 2 mg/kg per h, was initiated, but the skin lesions did not improve. HSV‐1 strain TAR was isolated and was shown to be resistant to aciclovir (IC50 36 μg/mL). HSV‐1 TAR and TAS were susceptible to vidarabine (IC50 4.4 and 2.9 μg/mL, respectively). The skin lesions were treated with i.v. vidarabine, 15–20 mg/kg per day, and healed satisfactorily. However, in March 1995, the patient again experienced a severe herpes simplex infection around the left eye. HSV‐1 strain R95 was isolated and was shown to be resistant to aciclovir (IC50 36 μg/mL). Diminished sensitivity of HSV‐1 TAR and R95 to aciclovir was associated with reduced viral TK activity and loss of aciclovir phosphorylation activity.
影响因子:
5.1
作者:
SULLIVAN, KE;MULLEN, CA;WINKELSTEIN, JA
通讯作者:
WINKELSTEIN, JA
DOI:
10.1093/infdis/161.6.1078
发表时间:
1990-06
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
S. Safrin;T. Assaykeen;S. Follansbee;J. Mills
通讯作者:
S. Safrin;T. Assaykeen;S. Follansbee;J. Mills